BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$1.86
−2.62%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 4.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.67x
- Price / sales
- 7.79x
- Price / cash flow
- -1.14x
Enterprise value
- Enterprise value
- $7.0M
- EV / sales
- 5.86x
- EV / EBITDA
- -31.02x
- EV / EBIT
- -0.67x
- Market cap
- $9.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026